PATHOGENESIS OF ACQUIRED IMMUNE DEFICIENCY SYNDROME
获得性免疫缺陷综合征的发病机制
基本信息
- 批准号:3548356
- 负责人:
- 金额:$ 18.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-30 至 1986-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS T lymphocyte cancer risk case history cell type communicable disease transmission disease /disorder model early diagnosis helper T lymphocyte hemophilia As hepatitis B virus group homosexuals immune complex immunologic assay /test interferons interleukin 2 leukocyte activation /transformation lymphokines male secondary infection semen serology /serodiagnosis sperm
项目摘要
The purpose of this investigation is to perform epidemiologic surveys and
immunologic tests that will provide information concerning risk factors and
will predict persons at risk for the Acquired Immune Deficiency Syndrome
(AIDS). The populations under study are 1) asymptomatic homosexual men; 2)
homosexual men with the chronic lymphadenopathy syndrome (CLS); 3)
homosexual men with and without evidence of hepatitis B virus (HBV)
infections; and 4) patients with hemophilia A. The initial studies will
establish the incidence and prevalence of AIDS in Denver, Colorado, a
community with a large homosexual population that does not yet have
residents with AIDS. Subsequent serial studies will identify risk factors
and establish the specificity and sensitivity of each immunologic test in
the panel. Patients with hemophilia will clarify the role of blood borne
transmissible agents in the pathogenesis of AIDS. The possible role of
sperm in development of the immuno-deficiency in AIDS will be examined.
本次调查的目的是进行流行病学调查和
免疫学测试将提供有关风险因素和
将预测有患获得性免疫缺陷综合症风险的人
(艾滋病)。研究中的人群是:1)无症状的同性恋男性;2)
患有慢性淋巴结病综合征(CLS)的男同性恋者;
有或没有乙肝病毒(乙肝)证据的同性恋者
感染;以及4)血友病A患者。初步研究将
建立科罗拉多州丹佛市艾滋病的发病率和流行率
拥有大量同性恋人口的社区还没有
患有艾滋病的居民。随后的系列研究将确定风险因素
并建立每一项免疫学试验的特异性和敏感性
电池板。血友病患者将阐明血液传播的作用
艾滋病发病机制中的传播性物质。可能起到的作用
对发育中的精子进行免疫缺陷艾滋病的检查。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners.
抗淋巴细胞抗体对获得性免疫缺陷综合征(艾滋病)患者及其性伴侣的意义。
- DOI:10.1007/bf00916007
- 发表时间:1987
- 期刊:
- 影响因子:9.1
- 作者:Ozturk,GE;Kohler,PF;HorsburghJr,CR;Kirkpatrick,CH
- 通讯作者:Kirkpatrick,CH
Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome.
患有全身性淋巴结病综合征或获得性免疫缺陷综合征的人会产生白介素 2。
- DOI:10.1007/bf00915166
- 发表时间:1985
- 期刊:
- 影响因子:9.1
- 作者:Kirkpatrick,CH;Davis,KC;HorsburghJr,CR;Cohn,DL;Penley,K;Judson,FN
- 通讯作者:Judson,FN
Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III).
血友病中免疫力的改变与人类 T 细胞嗜淋巴细胞病毒 III 型 (HTLV-III) 抗体的存在相关。
- DOI:10.1007/bf00915362
- 发表时间:1986
- 期刊:
- 影响因子:9.1
- 作者:HorsburghJr,CR;Davis,KC;Hasiba,U;Weiss,SH;Goedert,JJ;Sarin,P;Kirkpatrick,CH
- 通讯作者:Kirkpatrick,CH
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.
男同性恋者细胞免疫异常与 HTLV-III 抗体的关系。
- DOI:10.1016/0008-8749(86)90276-5
- 发表时间:1986
- 期刊:
- 影响因子:4.3
- 作者:Dobozin,BS;Judson,FN;Cohn,DL;Penley,KA;Rickmann,PE;Blaser,MJ;Sarin,PS;Weiss,SH;Kirkpatrick,CH
- 通讯作者:Kirkpatrick,CH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES HARVEY KIRKPATRICK其他文献
CHARLES HARVEY KIRKPATRICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES HARVEY KIRKPATRICK', 18)}}的其他基金
SUBCUTANEOUS FORMULATION OF ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
用于治疗遗传性血管性水肿的 Icatibant 皮下制剂
- 批准号:
7719495 - 财政年份:2008
- 资助金额:
$ 18.93万 - 项目类别:
STDY OF EFFICACY&SAFETY OF RCMBNNT C1 INHBTR 4 TRTMNT OF ACUTEATCKS OF ANGIOEDEM
功效研究
- 批准号:
7719489 - 财政年份:2008
- 资助金额:
$ 18.93万 - 项目类别:
STDY OF EFFICACY&SAFETY OF RCMBNNT C1 INHBTR 4 TRTMNT OF ACUTEATCKS OF ANGIOEDEM
功效研究
- 批准号:
7604439 - 财政年份:2007
- 资助金额:
$ 18.93万 - 项目类别:
SUBCUTANEOUS FORMULATION OF ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
用于治疗遗传性血管性水肿的 Icatibant 皮下制剂
- 批准号:
7604445 - 财政年份:2007
- 资助金额:
$ 18.93万 - 项目类别:
SUBCUTANEOUS FORMULATION OF ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
用于治疗遗传性血管性水肿的 Icatibant 皮下制剂
- 批准号:
7377860 - 财政年份:2006
- 资助金额:
$ 18.93万 - 项目类别:
STDY OF EFFICACY&SAFETY OF RCMBNNT C1 INHBTR 4 TRTMNT OF ACUTEATCKS OF ANGIOEDEM
功效研究
- 批准号:
7377855 - 财政年份:2006
- 资助金额:
$ 18.93万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 18.93万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 18.93万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 18.93万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




